Report Detail

Request for Sample of this report

Pharma & Healthcare Global mRNA Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4609425
    • |
  • 19 August, 2024
    • |
  • Global
    • |
  • 127 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global mRNA Flu Vaccine market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global mRNA Flu Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global mRNA Flu Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global mRNA Flu Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global mRNA Flu Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global mRNA Flu Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Flu Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Flu Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, BioNTech, CureVac, Novavax, Sanofi, Inovio Pharmaceuticals, Arcturus Therapeutics Holdings, eTheRNA immunotherapies, Valneva, Vaxart, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
mRNA Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
mRNA-1010
mRNA-1020
mRNA-1030
Market segment by Application
Hospital
Clinic
Other
Major players covered
Moderna
BioNTech
CureVac
Novavax
Sanofi
Inovio Pharmaceuticals
Arcturus Therapeutics Holdings
eTheRNA immunotherapies
Valneva
Vaxart
Entos Pharmaceuticals
Abnova Corporation
Anima Biotech
Sarepta Therapeutics
iBio
Barinthus Biotherapeutics
Alnylam Pharmaceuticals
Beam Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA Flu Vaccine, with price, sales quantity, revenue, and global market share of mRNA Flu Vaccine from 2019 to 2024.
Chapter 3, the mRNA Flu Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and mRNA Flu Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Flu Vaccine.
Chapter 14 and 15, to describe mRNA Flu Vaccine sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global mRNA Flu Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 mRNA-1010
    • 1.3.3 mRNA-1020
    • 1.3.4 mRNA-1030
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global mRNA Flu Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global mRNA Flu Vaccine Market Size & Forecast
    • 1.5.1 Global mRNA Flu Vaccine Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global mRNA Flu Vaccine Sales Quantity (2019-2030)
    • 1.5.3 Global mRNA Flu Vaccine Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Moderna
    • 2.1.1 Moderna Details
    • 2.1.2 Moderna Major Business
    • 2.1.3 Moderna mRNA Flu Vaccine Product and Services
    • 2.1.4 Moderna mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Moderna Recent Developments/Updates
  • 2.2 BioNTech
    • 2.2.1 BioNTech Details
    • 2.2.2 BioNTech Major Business
    • 2.2.3 BioNTech mRNA Flu Vaccine Product and Services
    • 2.2.4 BioNTech mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 BioNTech Recent Developments/Updates
  • 2.3 CureVac
    • 2.3.1 CureVac Details
    • 2.3.2 CureVac Major Business
    • 2.3.3 CureVac mRNA Flu Vaccine Product and Services
    • 2.3.4 CureVac mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 CureVac Recent Developments/Updates
  • 2.4 Novavax
    • 2.4.1 Novavax Details
    • 2.4.2 Novavax Major Business
    • 2.4.3 Novavax mRNA Flu Vaccine Product and Services
    • 2.4.4 Novavax mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Novavax Recent Developments/Updates
  • 2.5 Sanofi
    • 2.5.1 Sanofi Details
    • 2.5.2 Sanofi Major Business
    • 2.5.3 Sanofi mRNA Flu Vaccine Product and Services
    • 2.5.4 Sanofi mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sanofi Recent Developments/Updates
  • 2.6 Inovio Pharmaceuticals
    • 2.6.1 Inovio Pharmaceuticals Details
    • 2.6.2 Inovio Pharmaceuticals Major Business
    • 2.6.3 Inovio Pharmaceuticals mRNA Flu Vaccine Product and Services
    • 2.6.4 Inovio Pharmaceuticals mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Inovio Pharmaceuticals Recent Developments/Updates
  • 2.7 Arcturus Therapeutics Holdings
    • 2.7.1 Arcturus Therapeutics Holdings Details
    • 2.7.2 Arcturus Therapeutics Holdings Major Business
    • 2.7.3 Arcturus Therapeutics Holdings mRNA Flu Vaccine Product and Services
    • 2.7.4 Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Arcturus Therapeutics Holdings Recent Developments/Updates
  • 2.8 eTheRNA immunotherapies
    • 2.8.1 eTheRNA immunotherapies Details
    • 2.8.2 eTheRNA immunotherapies Major Business
    • 2.8.3 eTheRNA immunotherapies mRNA Flu Vaccine Product and Services
    • 2.8.4 eTheRNA immunotherapies mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 eTheRNA immunotherapies Recent Developments/Updates
  • 2.9 Valneva
    • 2.9.1 Valneva Details
    • 2.9.2 Valneva Major Business
    • 2.9.3 Valneva mRNA Flu Vaccine Product and Services
    • 2.9.4 Valneva mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Valneva Recent Developments/Updates
  • 2.10 Vaxart
    • 2.10.1 Vaxart Details
    • 2.10.2 Vaxart Major Business
    • 2.10.3 Vaxart mRNA Flu Vaccine Product and Services
    • 2.10.4 Vaxart mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Vaxart Recent Developments/Updates
  • 2.11 Entos Pharmaceuticals
    • 2.11.1 Entos Pharmaceuticals Details
    • 2.11.2 Entos Pharmaceuticals Major Business
    • 2.11.3 Entos Pharmaceuticals mRNA Flu Vaccine Product and Services
    • 2.11.4 Entos Pharmaceuticals mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Entos Pharmaceuticals Recent Developments/Updates
  • 2.12 Abnova Corporation
    • 2.12.1 Abnova Corporation Details
    • 2.12.2 Abnova Corporation Major Business
    • 2.12.3 Abnova Corporation mRNA Flu Vaccine Product and Services
    • 2.12.4 Abnova Corporation mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Abnova Corporation Recent Developments/Updates
  • 2.13 Anima Biotech
    • 2.13.1 Anima Biotech Details
    • 2.13.2 Anima Biotech Major Business
    • 2.13.3 Anima Biotech mRNA Flu Vaccine Product and Services
    • 2.13.4 Anima Biotech mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Anima Biotech Recent Developments/Updates
  • 2.14 Sarepta Therapeutics
    • 2.14.1 Sarepta Therapeutics Details
    • 2.14.2 Sarepta Therapeutics Major Business
    • 2.14.3 Sarepta Therapeutics mRNA Flu Vaccine Product and Services
    • 2.14.4 Sarepta Therapeutics mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Sarepta Therapeutics Recent Developments/Updates
  • 2.15 iBio
    • 2.15.1 iBio Details
    • 2.15.2 iBio Major Business
    • 2.15.3 iBio mRNA Flu Vaccine Product and Services
    • 2.15.4 iBio mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 iBio Recent Developments/Updates
  • 2.16 Barinthus Biotherapeutics
    • 2.16.1 Barinthus Biotherapeutics Details
    • 2.16.2 Barinthus Biotherapeutics Major Business
    • 2.16.3 Barinthus Biotherapeutics mRNA Flu Vaccine Product and Services
    • 2.16.4 Barinthus Biotherapeutics mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Barinthus Biotherapeutics Recent Developments/Updates
  • 2.17 Alnylam Pharmaceuticals
    • 2.17.1 Alnylam Pharmaceuticals Details
    • 2.17.2 Alnylam Pharmaceuticals Major Business
    • 2.17.3 Alnylam Pharmaceuticals mRNA Flu Vaccine Product and Services
    • 2.17.4 Alnylam Pharmaceuticals mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Alnylam Pharmaceuticals Recent Developments/Updates
  • 2.18 Beam Therapeutics
    • 2.18.1 Beam Therapeutics Details
    • 2.18.2 Beam Therapeutics Major Business
    • 2.18.3 Beam Therapeutics mRNA Flu Vaccine Product and Services
    • 2.18.4 Beam Therapeutics mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 Beam Therapeutics Recent Developments/Updates

3 Competitive Environment: mRNA Flu Vaccine by Manufacturer

  • 3.1 Global mRNA Flu Vaccine Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global mRNA Flu Vaccine Revenue by Manufacturer (2019-2024)
  • 3.3 Global mRNA Flu Vaccine Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of mRNA Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 mRNA Flu Vaccine Manufacturer Market Share in 2023
    • 3.4.3 Top 6 mRNA Flu Vaccine Manufacturer Market Share in 2023
  • 3.5 mRNA Flu Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 mRNA Flu Vaccine Market: Region Footprint
    • 3.5.2 mRNA Flu Vaccine Market: Company Product Type Footprint
    • 3.5.3 mRNA Flu Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global mRNA Flu Vaccine Market Size by Region
    • 4.1.1 Global mRNA Flu Vaccine Sales Quantity by Region (2019-2030)
    • 4.1.2 Global mRNA Flu Vaccine Consumption Value by Region (2019-2030)
    • 4.1.3 Global mRNA Flu Vaccine Average Price by Region (2019-2030)
  • 4.2 North America mRNA Flu Vaccine Consumption Value (2019-2030)
  • 4.3 Europe mRNA Flu Vaccine Consumption Value (2019-2030)
  • 4.4 Asia-Pacific mRNA Flu Vaccine Consumption Value (2019-2030)
  • 4.5 South America mRNA Flu Vaccine Consumption Value (2019-2030)
  • 4.6 Middle East & Africa mRNA Flu Vaccine Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global mRNA Flu Vaccine Sales Quantity by Type (2019-2030)
  • 5.2 Global mRNA Flu Vaccine Consumption Value by Type (2019-2030)
  • 5.3 Global mRNA Flu Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global mRNA Flu Vaccine Sales Quantity by Application (2019-2030)
  • 6.2 Global mRNA Flu Vaccine Consumption Value by Application (2019-2030)
  • 6.3 Global mRNA Flu Vaccine Average Price by Application (2019-2030)

7 North America

  • 7.1 North America mRNA Flu Vaccine Sales Quantity by Type (2019-2030)
  • 7.2 North America mRNA Flu Vaccine Sales Quantity by Application (2019-2030)
  • 7.3 North America mRNA Flu Vaccine Market Size by Country
    • 7.3.1 North America mRNA Flu Vaccine Sales Quantity by Country (2019-2030)
    • 7.3.2 North America mRNA Flu Vaccine Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe mRNA Flu Vaccine Sales Quantity by Type (2019-2030)
  • 8.2 Europe mRNA Flu Vaccine Sales Quantity by Application (2019-2030)
  • 8.3 Europe mRNA Flu Vaccine Market Size by Country
    • 8.3.1 Europe mRNA Flu Vaccine Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe mRNA Flu Vaccine Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific mRNA Flu Vaccine Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific mRNA Flu Vaccine Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific mRNA Flu Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific mRNA Flu Vaccine Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific mRNA Flu Vaccine Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America mRNA Flu Vaccine Sales Quantity by Type (2019-2030)
  • 10.2 South America mRNA Flu Vaccine Sales Quantity by Application (2019-2030)
  • 10.3 South America mRNA Flu Vaccine Market Size by Country
    • 10.3.1 South America mRNA Flu Vaccine Sales Quantity by Country (2019-2030)
    • 10.3.2 South America mRNA Flu Vaccine Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa mRNA Flu Vaccine Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa mRNA Flu Vaccine Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa mRNA Flu Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa mRNA Flu Vaccine Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa mRNA Flu Vaccine Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 mRNA Flu Vaccine Market Drivers
  • 12.2 mRNA Flu Vaccine Market Restraints
  • 12.3 mRNA Flu Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of mRNA Flu Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of mRNA Flu Vaccine
  • 13.3 mRNA Flu Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 mRNA Flu Vaccine Typical Distributors
  • 14.3 mRNA Flu Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on mRNA Flu Vaccine. Industry analysis & Market Report on mRNA Flu Vaccine is a syndicated market report, published as Global mRNA Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of mRNA Flu Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,651.76
    		3,977.64
    		5,303.52
    		3,138.96
    		4,708.44
    		6,277.92
    		490,540.80
    		735,811.20
    		981,081.60
    		292,180.80
    		438,271.20
    		584,361.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo